Category: Top Story
-
IBM introduces reference architecture for quantum-centric supercomputing
IBM (NYSE:IBM) on March 12, 2026 released its first reference architecture designed for quantum-centric supercomputing, outlining how quantum processors can be integrated with classical computing technologies such as CPUs and GPUs across on-premises systems, research facilities and cloud platforms. The framework links quantum hardware with traditional computing infrastructure, high-speed networking and shared data storage to…
-
Oil rebound could pressure Wall Street: Dow Jones, S&P, Nasdaq, Futures
U.S. stock futures suggest a weaker start to Thursday’s session, with markets likely to face pressure after the major indices finished largely unchanged for two consecutive days. A renewed surge in crude prices may weigh on investor sentiment, as oil extends its rebound following Tuesday’s sharp decline. U.S. crude for April delivery has jumped $6.12,…
-
Shell reports lower 2025 earnings as operating cash flow declines
Shell (NYSE:SHEL) reported adjusted earnings of $18.5 billion for 2025, compared with $23.7 billion recorded in the previous year. Cash flow generated from operations totaled $42.9 billion, down from $54.7 billion in 2024. Free cash flow also declined, coming in at $26.1 billion compared with $39.5 billion a year earlier. Despite the drop in cash…
-
US President Trump and the AI hyperscalers! Siemens Energy, Nordex, and Stallion Uranium shares in focus
Major AI companies in the US are taking on greater responsibility for the energy supply of their data centers. At a recent meeting with President Donald Trump, Microsoft, Alphabet, Meta, and others agreed that the boom should not come at the expense of private households. Siemens Energy is currently benefiting greatly from this. Gas-fired power…
-
A new drone contender: The potential of NEO Battery Materials, DroneShield, and Amprius Technologies
Energy efficiency and defense capabilities are two sides of the same coin. This is especially true in the rapidly growing drone business, where powerful batteries are crucial. While global demand for batteries continues to rise sharply, according to McKinsey’s analysis, the military sector is focusing on a highly specialized niche: maximizing energy density while eliminating…
-
U.S. Stocks Close Little Changed For Second Straight Day
Stocks showed a lack of direction over the course of the trading day on Wednesday, extending the lackluster performance seen in the previous session. The major averages once again spent the day bouncing back and forth across the unchanged line. The major averages eventually closed mixed for the second straight day. While the Nasdaq inched…
-
Meta reveals four new in-house AI chips to support data center expansion
Meta Platforms (NASDAQ:META) on Wednesday introduced four internally developed chips designed to handle artificial intelligence workloads as part of its broader data center growth strategy. The processors belong to the company’s Meta Training and Inference Accelerator (MTIA) family, first introduced in 2023 and followed by a second-generation model in 2024. Meta said it plans to…
-
Campbell Soup shares fall after earnings miss and lowered outlook
Campbell Soup Company (NASDAQ:CPB) shares dropped more than 5% in premarket trading Wednesday after the company reported fiscal second-quarter 2026 results that came in below expectations and cut its full-year guidance. The food producer reported earnings per share of $0.51 for the quarter, missing analyst forecasts of $0.57. Revenue totaled $2.6 billion, slightly under the…
-
Nike shares climb after Barclays upgrades stock to Overweight
Nike Inc. (NYSE:NKE) rose about 2% on Wednesday after Barclays upgraded the sportswear giant to Overweight from Equalweight and lifted its price target to $73 from $64. Barclays analyst Adrienne Yih said the upgrade reflects recent operational improvements, financial turning points and management’s disciplined execution. “While acknowledging ongoing risks, we believe the risk/reward profile has…
-
Eli Lilly plans $3 billion China investment, files for approval of new GLP-1 treatment
Eli Lilly and Company (NYSE:LLY) said it intends to invest about $3 billion in China over the next ten years to expand manufacturing capacity for its experimental treatment for type 2 diabetes and obesity, orforglipron. The pharmaceutical group also confirmed that it submitted a marketing application for the drug to China’s medicines regulator at the…